openPR Logo
Press release

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market is Projected to Reach Around USD 4212.53 Million By the End of 2030 with a Growing CAGR of 9.06% | Infinium Global Research

12-07-2023 02:30 PM CET | Health & Medicine

Press release from: Infinium Global Research LLP

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market

Infinium Global Research, a distinguished provider of market insights, introduces an exhaustive report unraveling the global and regional dynamics of the 23 Valent Pneumococcal Polysaccharide Vaccine Market. This comprehensive study delves into the market's segments, trends, forecasts, and dollar values, offering unparalleled insights for stakeholders in the pharmaceutical and healthcare sectors.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/407

Market Insight:

The global 23 valent pneumococcal polysaccharide vaccine market, valued at USD 2,112.97 million in 2022, is poised to soar to USD 4,212.53 million by 2030, projecting a substantial CAGR of 9.06% during the forecast period from 2023 to 2030.

Market Dynamics:

The 23-valent pneumococcal polysaccharide vaccine stands as a pivotal preventive measure against severe pneumococcal diseases, covering 23 different strains of Streptococcus pneumonia bacteria. It plays a critical role in averting diseases like pneumonia, meningitis, and bloodstream infections. With a heightened emphasis on preventive healthcare and the expansion of vaccination programs globally, the market for this vaccine anticipates substantial growth. Market participants engaged in manufacturing and distributing this vaccine are poised for innovation and expansion opportunities.

Drivers and Growth Factors:

The market's growth is propelled by the surging geriatric population and government-driven immunization programs. The rise in global aging populations intensifies the need for vaccination against pneumococcal diseases, fostering considerable demand for the 23-valent vaccine. However, pricing issues in low-income regions impede accessibility. Conversely, the continuous expansion of vaccination programs presents a significant growth opportunity for the market.

Regional Market Insights:

North America is poised to dominate the 23 valent pneumococcal polysaccharide vaccine market, leveraging robust healthcare infrastructure, high awareness levels, and proactive government initiatives promoting immunization. Meanwhile, the Asia Pacific region emerges as the fastest-growing market due to increasing healthcare expenditure, heightened vaccination awareness, and a burgeoning elderly population.

Segmentation Insights:

The report dissects segments including type (pre-filled syringe, single dose vial), age group (2-10 years, 10-64 years, 64+ years), and distribution channels (hospitals, clinics, and others).

Key Players Profiled:

Profiles of industry frontrunners such as Merck & Co., Inc., GSK plc., and Sanofi, among others, are featured in the report, offering insights into their strategies and market positioning.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/407

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. 23 Valent Pneumococcal Polysaccharide Vaccine Market Highlights

2.2. 23 Valent Pneumococcal Polysaccharide Vaccine Market Projection

2.3. 23 Valent Pneumococcal Polysaccharide Vaccine Market Regional Highlights

Chapter 3. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Type

3.4.2. IGR-Growth Matrix Analysis by Age Group

3.4.3. IGR-Growth Matrix Analysis by Distribution Channel

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of 23 Valent Pneumococcal Polysaccharide Vaccine Market

Chapter 4. 23 Valent Pneumococcal Polysaccharide Vaccine Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global 23 Valent Pneumococcal Polysaccharide Vaccine Market

5.2. Companies Profiles

5.2.1. Merck & Co., Inc.

5.2.2. GSK plc.

5.2.3. Walvax Biotechnology Co., Ltd.

5.2.4. Zhi Fei Biological

5.2.5. SINOVAC

5.2.6. Chengdu Institute of Biology (CIB)

5.2.7. Sanofi

5.2.8. Pfizer Inc.

5.2.9. Beijing Minhai Biological Technology Co., Ltd.

5.2.10. Serum Institute of India Pvt. Ltd.

Chapter 6. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

6.1. Pre-filled Syringe

6.2. Single Dose Vial

Chapter 7. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

7.1. 2-10 Years

7.2. 10-64 Years

7.3. 64+ Years

Chapter 8. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

8.1. Hospitals

8.2. Clinics

8.3. Others

Chapter 9. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Region 2023-2030

9.1. North America

9.1.1. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.1.2. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.1.3. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.1.4. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Country

9.1.4.1. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.1.4.1.1. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.1.4.1.2. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.1.4.1.3. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.1.4.2. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.1.4.2.1. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.1.4.2.2. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.1.4.2.3. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.1.4.3. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.1.4.3.1. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.1.4.3.2. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.1.4.3.3. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.2. Europe

9.2.1. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.2.2. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.2.3. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.2.4. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Country

9.2.4.1. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.2.4.1.1. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.2.4.1.2. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.2.4.1.3. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.2.4.2. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.2.4.2.1. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.2.4.2.2. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.2.4.2.3. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.2.4.3. France 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.2.4.3.1. France 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.2.4.3.2. France 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.2.4.3.3. France 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.2.4.4. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.2.4.4.1. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.2.4.4.2. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.2.4.4.3. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.2.4.5. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.2.4.5.1. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.2.4.5.2. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.2.4.5.3. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.3. Asia Pacific

9.3.1. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.3.2. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.3.3. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.3.4. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Country

9.3.4.1. China 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.3.4.1.1. China 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.3.4.1.2. China 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.3.4.1.3. China 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.3.4.2. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.3.4.2.1. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.3.4.2.2. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.3.4.2.3. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.3.4.3. India 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.3.4.3.1. India 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.3.4.3.2. India 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.3.4.3.3. India 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.3.4.4. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.3.4.4.1. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.3.4.4.2. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.3.4.4.3. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.3.4.5. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.3.4.5.1. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.3.4.5.2. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.3.4.5.3. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.3.4.6. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.3.4.6.1. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.3.4.6.2. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.3.4.6.3. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.4. RoW

9.4.1. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.4.2. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.4.3. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.4.4. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Sub-region

9.4.4.1. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.4.4.1.1. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.4.4.1.2. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.4.4.1.3. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.4.4.2. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.4.4.2.1. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.4.4.2.2. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.4.4.2.3. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

9.4.4.3. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market

9.4.4.3.1. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type

9.4.4.3.2. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group

9.4.4.3.3. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/407

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of 23 valent pneumococcal polysaccharide vaccine.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global 23 Valent Pneumococcal Polysaccharide Vaccine Market is Projected to Reach Around USD 4212.53 Million By the End of 2030 with a Growing CAGR of 9.06% | Infinium Global Research here

News-ID: 3319699 • Views:

More Releases from Infinium Global Research LLP

Electric Vehicle Motor Market Outlook 2024-2032: Strong Growth to USD 1451.05 Million
Electric Vehicle Motor Market Outlook 2024-2032: Strong Growth to USD 1451.05 Mi …
✅ Market Overview The global electric vehicle motor market has been witnessing rapid growth, fueled by rising adoption of battery electric vehicles (BEVs), government incentives, and technological innovations. In 2023, the market was valued at USD 745.23 million, and it is projected to reach USD 1,451.05 million by 2032, expanding at a CAGR of 8.04% between 2024 and 2032. Electric vehicle motors are at the core of the transition toward sustainable mobility.
Aircraft Landing Gear Market Growth Driven by Demand, Expected to Reach USD 18.8 Billion by 2032
Aircraft Landing Gear Market Growth Driven by Demand, Expected to Reach USD 18.8 …
✅ Market Overview The global aircraft landing gear market is entering a new phase of steady growth, driven by rising air travel demand, fleet modernization programs, and defense spending. According to recent estimates, the market was valued at USD 14,521.7 million in 2025 and is projected to reach USD 18,822.3 million by 2032, registering a CAGR of 3.81% during 2026-2032. Landing gear is a vital subsystem in every aircraft, enabling safe takeoff,
Air Ambulance Services Market Forecast 2026-2032: Strong Growth to USD 10,176.8 Million
Air Ambulance Services Market Forecast 2026-2032: Strong Growth to USD 10,176.8 …
✅ Market Overview The global air ambulance services market is gaining strong momentum as healthcare systems worldwide place greater emphasis on rapid emergency response and advanced patient care. In 2025, the market was valued at USD 6,690.1 million and is projected to reach USD 10,176.8 million by 2032, expanding at a CAGR of 6.23% between 2026 and 2032. This growth reflects the rising demand for critical patient transfers, increased medical emergencies,
Aircraft Maintenance Tooling Market Valued at USD 3761.4 Million in 2025, Projected to Reach USD 4634.6 Million by 2032
Aircraft Maintenance Tooling Market Valued at USD 3761.4 Million in 2025, Projec …
✅ Overview of the Aircraft Maintenance Tooling Market The global aircraft maintenance tooling market was valued at USD 3,761.4 million in 2025 and is projected to reach USD 4,634.6 million by 2032, growing at a CAGR of 3.07% between 2026 and 2032. This market plays a critical role in aviation, as it supplies the precision instruments and tools necessary for safe, efficient, and timely aircraft maintenance. From wrenches and safety wire

All 5 Releases


More Releases for Valent

HPV 9-Valent Vaccine Market Set to Double by 2034
The global fight against human papillomavirus (HPV)-a major cause of cervical and other cancers-has entered a pivotal phase. At the forefront is the 9-valent HPV vaccine, a medical breakthrough that offers protection against nine HPV strains responsible for over 90% of cervical cancer cases. As governments and healthcare organizations prioritize mass immunization and awareness, the HPV 9-valent vaccine market is witnessing robust growth. According to Exactitude Consultancy, the global HPV 9-valent
Zero Valent Iron Market Comprehensive Study Explore Huge Growth in Future
Latest added Zero Valent Iron Market research study by AMA Research offers detailed outlook and elaborates market review till 2028. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are GMA Industries Inc (United States), American Elements (United States), SAGWELL USA INC (United States), Peerless
Fenpyrazamine Market: Leading Segments and their Growth Drivers | Valent, Sumito …
"In this comprehensive Fenpyrazamine report, we delve deep into the global TechSphere, leaving no stone unturned in our quest for insights. Our seasoned team of analysts has harnessed cutting-edge research tools and techniques to fathom the dimensions of the technology Fenpyrazamine market. Our findings encompass both the quantitative and qualitative aspects, offering valuable insights for industry stakeholders. We've meticulously dissected the Fenpyrazamine market landscape, scrutinizing every nook and cranny, from
Microbials Market Exceptional Business Performance | Taxon (Dupont), Brettyoung, …
Report Ocean recently published a new report on the Global Microbials Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Microbials Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Microbials Market situation of the leading key players, key market trends, and potential market growth areas.
Microbial Products Market | Pfizer Inc., GlaxoSmithKline plc, Valent BioSciences …
Global Microbial Products Market: Overview Industrial microbiology encompasses the use of microorganisms and their metabolites for a wide variety of industrial products. Products derived from microbial products include a variety of beverages, food additives, healthcare products, and biofuels. Microbial products have been extensively utilized in fermentation processes for the commercial production of a range of enzymes such as cellulose, amylase, protease, lipase, streptokinase, and pectinase, and various types of antibiotics in
Global10-Valent Pneumococcal Polysaccharide Vaccine Market Emerging Trends & Gro …
The global market status for 10-Valent Pneumococcal Polysaccharide Vaccine is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global 10-Valent Pneumococcal Polysaccharide Vaccine Market” Insights, Forecast to 2025, which tends to deliver in-depth knowledge associated to the 10-Valent Pneumococcal Polysaccharide Vaccine market for the present and forecasted period until 2025. Furthermore, the report examines the target